Telmisartan/HCTZ 80 mg/12.5 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Telmisartan/HCTZ 80 mg/12.5 mg, covering 2017-12-28 to 2017-12-28. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension [Phase 3]